Table 3 Differences between CKD/ESKD participants with and without VC
Demographic features | VC present (n = 13) | VC absent (n = 21) | P value |
|---|---|---|---|
Age, years | 57 ± 13 | 59 ± 18 | 0.60 |
Sex (male) | 8 (61%) | 17 (80%) | 0.21 |
BMI (kg/m2) | 27 ± 4 | 29 ± 6 | 0.24 |
Time on dialysis (if ESKD), years | 2.5 [1.77–6] | 4.2 [2–6.5] | 0.25 |
CKD stage | |||
 Pre-dialysis | 1 (eGFR 17 ml/min2) | 2 (mean eGFR 20 ± 0.7 ml/min2) |  |
 PD | 4 | 1 |  |
 HD | 8 (57%) | 18 (86%) |  |
Diabetes | 4 (30%) | 9 (42%) | 0.55 |
Hypertension | 10 (77%) | 14 (67%) | 0.52 |
IHD | 3 (23%) | 4 (19%) | 0.78 |
PVD | 1 (7%) | 3 (14%) | 0.56 |
Smoker (current or former) | 8 (57%) | 15 (50%) | 0.66 |
Previous parathyroidectomy | 2 (15%) | 2 (9%) | 0.64 |
Calcitriol use | 7 (50%) | 10 (34%) | 0.24 |
Non-calcium-based binder | 7 (50%) | 11 (38%) | 0.35 |
Calcium based binder | 2 (15%) | 10 (47%) | 0.06 |
PTH, pmol/L | 58 [37–184] | 66 [37–123] | 0.41 |
Total calcium, mmol/L | 2.3 ± 0.2 | 2.4 ± 0.2 | 0.57 |
Phosphate, mmol/L | 2 ± 0.5 | 1.9 ± 0.7 | 0.71 |
ALP, IU/L | 106 [76–207] | 108 [81–139] | 0.72 |
Vessel number | 44 ± 19 | 39 ± 15 | 0.91 |
Perieccrine calcification | 9 (69%) | 4 (19%) | 0.003 |